Company news
Nuwellis, Inc. (NASDAQ:NUWE) news
Every Nuwellis, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Nuwellis Expands Critical Care Portfolio Through Strategic Commercial Agreement with Atrility Medical
August 25, 2026
Nuwellis Reports Second Quarter 2026 Financial Results and Business Highlights Focused on Double Digit Revenue Growth and Expanded Gross ...
August 13, 2026
Nuwellis Accelerates Digital Transformation of the Aquadex® Platform with EHR Connectivity and Enhanced User Interface
August 11, 2026
Nuwellis Announces Next-Generation Aquadex Platform Strategy to Expand Future Critical Care Applications
August 4, 2026
Nuwellis Announces Pricing of $3.4 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
July 31, 2026
Nuwellis Announces Acceptance by Frontiers in Pediatrics of New Single-Center Retrospective Study Supporting Alternative Anticoagulation ...
July 30, 2026
Nuwellis Expands Pediatric Footprint with First Aquadex SmartFlow® Installations in Wisconsin
July 28, 2026
Nuwellis Announces Preliminary Revenue Results for the Second Quarter 2026 Showing Double Digit Growth
July 27, 2026
Nuwellis Awarded U.S. Patent for Novel Catheter Technology Designed to Enhance Extracorporeal Therapies
July 16, 2026
Nuwellis to Showcase Aquadex Therapy at KidneyBee Summit 2026
July 7, 2026
Nuwellis Celebrates Five Years of Support of the Pediatric Cardiac Critical Care Consortium (PC⁴)
June 26, 2026
Nuwellis Announces Pediatric Expansion in Michigan with First Aquadex SmartFlow® Installations
June 25, 2026
Incoming Nuwellis CEO Mike McCormick Underscores Strategic Priorities for Continued Market Expansion in Pediatric Category and Revenue Ge...
June 24, 2026
Nuwellis Expands Critical Care Education with Aquadex Training at University of Minnesota Critical Care Cardiology Education Summit
June 18, 2026
Nuwellis Appoints Mike McCormick as Chief Executive Officer
June 16, 2026
Nuwellis Expands Collaboration with Major South Carolina Healthcare System to Install New Aquadex SmartFlow® Devices at One of its Childr...
June 10, 2026
Nuwellis Announces Closing of $6.0 Million Registered Public Offering
June 8, 2026
Nuwellis Announces Pricing of $6 Million Public Offering
June 5, 2026
Nuwellis Announces Successful Completion of FDA Pre-Submission 510(k) Meeting to Expand Aquadex Label
May 14, 2026
Nuwellis, Inc. Announces First Quarter 2026 Financial Results
May 12, 2026
Nuwellis, Inc. To Announce First Quarter 2026 Financial Results on May 12, 2026
May 5, 2026
Nuwellis Highlights Case Study Featuring Precision Ultrafiltration Therapy in Pediatric Cardiorenal Care at ISHLT 2026 Annual Meeting
April 29, 2026
Nuwellis Announces Receipt of a Notice of Allowance from the U.S. Patent and Trademark Office for Innovative Dual Lumen Midline Catheter ...
April 28, 2026
Nuwellis to Participate in the AATS 106th Annual Meeting and ERAS Cardiac Spring Retreat
April 23, 2026
Nuwellis Announces Aquadex Software Update
April 21, 2026
Nuwellis Welcomes Back Three Former Team Members to Accelerate Commercial and Clinical Momentum
April 16, 2026
Nuwellis Engages CORE IR for Public Relations, Shareholder Communications, and Social Media Management Services
April 9, 2026
Nuwellis Strengthens Commercial Infrastructure with New South Texas Territory
April 7, 2026
Nuwellis Pediatric Category Achieves Approximately 50% of Total U.S. Revenue in 2025, Marking Growth Milestone
March 31, 2026
Nuwellis Completes Acquisition of Rendiatech
March 17, 2026
Nuwellis, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results
March 10, 2026
Nuwellis Appoints Dr. Stuart L. Goldstein as Director of Clinical Strategy to Advance Pediatric and Cardiorenal Strategy
March 5, 2026
Nuwellis Appoints David A. McDonald and Martin J. Emerson to Board of Directors
February 26, 2026
Nuwellis, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026
February 24, 2026
Nuwellis Appoints Carisa Schultz as Chief Financial Officer
January 30, 2026
Nuwellis Announces $5 Million Private Placement and Warrant Inducement Transaction, Priced At-The-Market
January 29, 2026
Nuwellis Enters into Definitive Agreement to Acquire Rendiatech, Advancing Its Cardiorenal Portfolio Strategy
January 29, 2026
Nuwellis Announces Changes to Board of Directors
January 23, 2026
Nuwellis Announces Issuance of New U.S. Patent Supporting Advanced Safety Design for Pediatric Extracorporeal Therapy
January 6, 2026
Lenox Hill Hospital Study Highlights the Broad Utility of Aquadex in Managing Fluid Overload Across Critical Care Settings
December 9, 2025
Nuwellis Continues Clinician-Driven Growth in Pediatric Care with a Leading Hospital in the Northeast U.S.
December 4, 2025
Nuwellis Reports Third Quarter 2025 Results and Continued Operational Momentum
November 12, 2025
Nuwellis Receives Notice of Allowance of a New U.S. Patent Strengthening Vivian™ Pediatric System with Advanced Clamp Safety Technology
November 10, 2025
Nuwellis, Inc. To Report Third Quarter 2025 Financial Results on November 12, 2025
October 23, 2025
Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatme...
September 30, 2025
Nuwellis Receives New US Patent Reinforcing Vivian™ Pediatric Device Focused on Safer, More Precise Ultrafiltration
September 18, 2025
Nuwellis, Inc. Participates in a Virtual Investor “What This Means” Segment
September 17, 2025
Nuwellis’ Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio
September 9, 2025
Nuwellis Introduces New 24-Hour Aquadex™ Circuit to Support Hospital-Based Outpatient and Short-Term Fluid Management
September 4, 2025
Nuwellis Receives FDA 510(k) Clearance for New Dual Lumen Extended Length Catheter
August 21, 2025